


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-3.10%
-2.01%
+0.07%
+17.54%
WST
West Pharmaceutical
$236.66
Strengths

Upgraded on attractively valued

Pays a reliable dividend
Risk Analysis

Earnings are forecast to decrease
WST Price Performance
$276.33 (-14.36%)
$284.86 (-16.92%)
$248.79 (-4.88%)
$322.28 (-26.57%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to decrease
![]()
WST Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WST Street Sentiment is bullish and have positive views on the near-term outlook
WST has Low risk level
Risks Indicators

Beta greater than 1.0

What is WST current stock price?
What are WST stock strengths?
What is WST Risk Level?
What is WST market cap and volume?
What is WST current Stock IQ?
Should I buy WST stock right now?
Is WST a Strong Buy right now?
What does a 'Strong Buy' rating mean for WST?
What does a 'Strong Sell' rating mean for WST?
What factors influence WST's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-3.10%
-2.01%
+0.07%
+17.54%
WST
West Pharmaceutical
Current Price
$236.66
Stock Insights
Strengths

Upgraded on attractively valued

Pays a reliable dividend
Risk Analysis

Earnings are forecast to decrease

WST Price Performance
$276.33 (-14.36%)
$284.86 (-16.92%)
$248.79 (-4.88%)
$322.28 (-26.57%)
WST Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to decrease
![]()
WST Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
WST Street Sentiment is bullish and have positive views on the near-term outlook
WST has Low risk level
Risks Indicators

Beta greater than 1.0

Overall Wall Street Rating
STRONG BUY
Today
Upgrade
Buy
Zacks
Nov 04, 2025
Initiate
Buy
TD Cowen
Oct 30, 2025
Initiate
Buy
TD Cowen
Oct 25, 2025
Reiterate
Buy
UBS
Oct 25, 2025
Reiterate
Overweight
KeyBanc
WST Stock IQ
WST Latest Analysis
WST Launches Synchrony S1 Prefillable Syringe at Pharmapack. West Pharmaceutical debuts the Synchrony S1 prefillable syringe at Pharmapack 2026 enhancing biologics vaccines and home-care support.
Fri Jan 23, 2026
West Pharmaceutical Services Becomes Oversold (WST). Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Fri Jan 23, 2026
All You Need to Know About West Pharmaceutical (WST) Rating Upgrade to Strong Buy. West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Thu Jan 22, 2026
After Plunging 9.7% in 4 Weeks Heres Why the Trend Might Reverse for West Pharmaceutical (WST). The heavy selling pressure might have exhausted for West Pharmaceutical (WST) as it is technically in oversold territory now. In addition to this technical measure strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Wed Jan 21, 2026
West Pharmaceutical Services Inc. (WST) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow.
Wed Jan 14, 2026
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now. WST is riding on surging GLP-1 demand and HVP expansion. Yet pricing pressure tariff risks and contract manufacturing headwinds cloud the near-term outlook.
Wed Jan 14, 2026
West Pharmaceutical Services Inc. (WST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.
Wed Jan 14, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.